Table 2.
Variable | Group | Outcome Measure in Time Point = (unadjusted) | Change over Time (adjusted) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Time 1: Baseline | Time 3: Three Months Later | Time 3 – 1: From Baseline to 3 Months | ||||||||
| ||||||||||
N = 188 | Mean (SD) | Between group P-value | N = 176 | Mean (SD) | Between group P-value | Mean (95% CI) | Within Group P-value | Between group P-value | ||
Medication Adherence (MA) | 95 | 83.9 (19.2) | 0.45 | 89 | 89.7 (11.9) | 0.86 | 5.7 (2.5 to 8.8) | <0.001 | 0.33 | |
iDecide | 93 | 87.2 (13.7) | 87 | 90.5 (10.8) | 3.4 (0.2 to 6.6) | 0.036 | ||||
| ||||||||||
MAIN OUTCOME VARIABES | ||||||||||
| ||||||||||
Satisfaction with Medication Information (SMI) | 95 | 77.4 (28.7) | 0.10 | 89 | 87.6 (17.9) | 0.29 | 10.2 (4.5 to 15.9) | <0.001 | 0.007 | |
iDecide | 93 | 68.6 (33.4) | 87 | 90.4 (17.2) | 21.5 (15.7 to 27.3) | <0.001 | ||||
Medication Knowledge (MK) | 95 | 34.8 (17.4) | 0.93 | 89 | 45.7 (21.8) | 0.84 | 10.8 (6.4 to 15.1) | <0.001 | 0.51 | |
iDecide | 93 | 34.8 (17.6) | 87 | 47.4 (18.5) | 12.8 (8.4 to 17.2) | <0.001 | ||||
Decisional Conflict (DC) | 95 | 60.7 (16.2) | 0.07 | 89 | 72.3 (13.2) | 0.53 | 11.5 (8.2 to 14.8) | <0.001 | 0.3 | |
iDecide | 93 | 56.6 (15.7) | 86 | 70.9 (13.7) | 14.1 (10.7 to 17.4) | <0.001 | ||||
| ||||||||||
POTENTIAL MEDIATORS | ||||||||||
| ||||||||||
Self-Efficacy (SE) | 95 | 75.0 (19.2) | 0.98 | 89 | 80.0 (16.6) | 0.05 | 4.8 (1.8 to 7.7) | 0.002 | 0.13 | |
iDecide | 93 | 74.6 (19.3) | 87 | 83.3 (19.5) | 8.1 (5.0 to 11.1) | <0.001 | ||||
Diabetes Distress (DD) | 95 | 68.0 (26.5) | 0.21 | 89 | 66.5 (30.7) | 0.05 | −1.6 (−6.9 to 3.7) | 0.555 | <0.001 | |
iDecide | 93 | 62.7 (28.3) | 87 | 76.9 (22.3) | 14.1 (8.7 to 19.5) | <0.001 |
Note: Means of each outcome measure at each time point are unadjusted. Means in changes in each outcome measure are estimated from linear mixed-effect models, adjusted for baseline health literacy. All self-reported scales have a range of 0–100 with more positive outcomes reflected by higher numbers (e.g., less medication decisional conflict, higher levels of self-reported medication adherence, and lower diabetes distress are closer to 100). P-values are bolded if less than 0.05.